GE Healthcare Collaborates with RaySearch to Improve Radiation Oncology Treatment Planning

Chicago/Stockholm – May 9, 2022: GE Healthcare is proud to announce that it has entered into an agreement to collaborate with RaySearch Laboratories AB (publ), a leading radiation oncology software provider, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to simplify how radiation will be targeted to shrink a tumor.... Read more

New BD Reagents Enable Researchers to Break Through Resolution Boundaries in Flow Cytometry

Developed with novel dye technology and AI guidance, new BD Horizon RealYellow™ 586 Reagents have potential to accelerate discovery and drug development in oncology, autoimmune disorders and infectious diseases FRANKLIN LAKES, N.J., April 25, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of... Read more

Researchers Use C. elegans to Study Aging and Age-Related Diseases

Aging is a universal trait among all organisms. From a public health perspective, with aging comes an increased risk of disease, including Alzheimer’s, cancer and metabolic disease/type II diabetes. Dr. Vilchez (right) and Dr. Koyuncu examining a C. elegans sample. Dr. David Vilchez heads a lab at CECAD, (Cellular Stress Responses in Aging-Associated Diseases), at... Read more

Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research

Bruker launches novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen’s HiPLEX-IHC peptide code antibody probes, combined with unbiased lipidomics, glycomics and metabolomics tissue imaging New Canopy CellScape™ single cell, highly quantitative spatial proteomic ChipCytometry™ platform features fully automated iterative staining using open-source antibodies for virtually unlimited immuno-oncology marker analysis on whole tissue... Read more

PerkinElmer Showcases Expanded Technology and Solutions Portfolio to Accelerate Cancer Research at AACR Annual Meeting

Innovative solutions offer researchers flexible therapeutic tools to deepen understanding of cancer’s biology to enable advances in immunotherapy, targeted treatments, and personalized medicine WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, will be at The American Association for Cancer Research (AACR) Annual Meeting from April 8-13 in New Orleans (booths... Read more

HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology

MENLO PARK, Calif., March 31, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, announced today PacBio’s essential contribution to the completion of the first truly complete human reference genome. The Telomere-to-Telomere (T2T) Consortium, an international team of scientists from the US National Human Genome Research Institute and... Read more

Using Zebrafish to Spark Student Interest in Science

BioEYES is a K-12 science education program that caught our attention with its use of classroom microscopes to visualize its primary teaching tool, zebrafish. We were further impressed to learn this organization has served over 155,000 students in thirteen global locations. ZEISS had recently donated a ZEISS Stemi 305 stereo microscope to the Philadelphia, USA,... Read more

PerkinElmer Launches ChemDraw® V21 Software, Empowering Researchers to Rapidly Create Chemically Intelligent Microsoft PowerPoint Reports

Ability to import 3D molecular models with one click accelerates information sharing, collaboration and decision making WALTHAM, Mass. – March 2, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw® software featuring the ability to import, animate and share 3D chemical structures natively in... Read more

TetraScience Announces Collaboration with PerkinElmer to Provide Signals Research™ Suite Customers with Accelerated Time to Value and Improved Scientific Data Outcomes

Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more